Abstract. Tumor-infiltrating lymphocytes are associated with the response to neoadjuvent chemotherapy and prognosis in breast cancer. However, the distribution, interaction and prognostic value of tumor-infiltrating T cells, the main component of the tumor microenvironment, have seldom been reported. In the present study, surgical specimens of 72 breast cancer patients were analyzed. Tumor-infiltrating T cell subsets ) and significantly inhibited the cytokine secretion of T cells. These results reveal the distribution and interaction of tumor-infiltrating T cell subsets, and indicate that CD8 + T cells and regulatory T cells may be used as reliable predictors of prognosis in breast cancer.
Introduction
The role of the immune system in the origin, development and metastasis of cancer is gradually being elucidated (1) (2) (3) and is being taken into consideration in anticancer treatment (4) (5) (6) . For example, the predictive and prognostic value of tumor-infiltrating lymphocytes (TILs) in various tumors, especially breast cancer (BC), was recently investigated (7) (8) (9) . The main infiltrating cells of the immune system in BC are T cells, and accumulating evidence suggests that immune activity mediated by T cells is critical for a sustained and effective antitumor response (10) . A previous study involving semi-quantitative hematoxylin-eosin staining demonstrated that triple-negative breast cancer (TNBC) exhibited a high infiltration of cluster of differentiation (CD)4 + T cells, CD8 + T cells and regulatory T cells (Tregs) (11) . However, the exact numbers of these cells and discrepancies between tumor, and healthy tissue are seldom reported. Therefore, a more accurate and detailed analysis is needed to determine the distribution of tumor-infiltrating T cells in BC.
Tregs are a subset of CD4 + T cells that regulate immune responses to pathogens and maintain self-tolerance. The forkhead box P3 protein (FOXP3) controls immune system development and function, and serves a crucial role in the generation of Tregs (12) . The infiltration of Tregs was reported in a variety of malignancies, including BC and can effectively inhibit anti-tumor responses (13) (14) (15) Therefore, the present study aimed to assess the distribution and interaction of tumor-infiltrating T cell subsets in BC. Additionally, the prognostic value of CD4, CD8A and FOXP3 expression in BC was evaluated using The Cancer Genome Atlas (TCGA) database. ). For ER and PR, cases with ≥1% positive staining as performed according to a previously published protocol (11) were considered positive, and patients with HER2 3 + or the presence of HER2 amplification were considered HER2-positive. The Ki67 index was also determined in all patients (11) .
Materials and methods

Patient
Processing of genomic data from TCGA. Publicly available TCGA data including 1,085 BC patients was downloaded from http://www.cbioportal.org and used in this study (21) . Gene Expression Profiling Interactive Analysis (21) , an interactive web server, was used for cancer and normal gene expression profiling and interactive analysis. A total of 69 BC patients who are male, presented with distant metastasis or received neoadjuvant chemotherapy were excluded in the further survival analysis. The best cut-off for CD4, CD8A and FOXP3 mRNA expression was 10.32, 7.47 and 6.55 separately which was defined by the receiver operating characteristic curve. Information regarding the 291 normal patients referred to as healthy women without infectious disease in the last 6 months was also obtained from this site.
Hematoxylin and eosin (H&E) staining. Sections (4 µm) were deparaffinized with 2 changes of xylene for 10 min each. The BC sections were hydrated by passing through decreasing alcohol series (100, 95 and 70%). Slides were stained in hematoxylin for 8 min at room temperature and then washed in running tap water for 5 min. 1% acidified alcohol was used for differentiation (1% HCl in 70% alcohol) for 2 min. Sections were washed in running tap water until the sections were blue again by dipping in an alkaline solution followed by another tap water wash. Then the sections were stained in 1% eosin Y for 5 min at room temperature. Sections were washed in tap water for 3 min and dehydrated in increasing concentration of alcohols and cleared in xylene.
Quantification of TILs.
A semi-quantitative H&E method was used to evaluate the TILs (22) . Histopathological analysis of the lymphocyte infiltrate was performed on H&E-stained sections (22) . All tumor H&E-stained slides were observed at x100 or x400 magnification (OLYMPUS CX23; Olympus Corporation, Tokyo, Japan). Stromal TILs were defined as the percentage of tumor stroma area containing a lymphocytic infiltrate without direct contact to tumor cells. In heterogenous tumors, different regions were evaluated and the average percentages of TILs were reported. During H&E evaluation, the cutoff percentages for low TILs and high TILs were <60% and >60% in BC tissue, respectively.
Flow cytometry. Flow cytometry was used to evaluate the density of TILs. This was evaluated as the average number of CD45 + cells per gram. In the present study the H&E slides with 60% TILs from the 72 patients were chosen for subsequent analysis, and the TIL density of the same patient was calculated by flow cytometry. Low and high groups were defined as CD45 + events/g tissue <300,000 and ≥300,000, respectively.
Freshly resected tissue was manually minced and then incubated for 60 min at 37˚C in a rocking table bed (120 rpm/min) with 1.0 mg/ml collagenase type IV (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 100 µg/ml DNase I (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) diluted in RPMI Medium (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) without fetal bovine serum (FBS). Single cell suspensions were prepared by filtering through 70-µm nylon strainers (BD Biosciences, Franklin Lakes, NJ, USA). Zombie Yellow (BioLegend, Inc., San Diego, CA, USA) was used to discriminate live and dead cells according to the manufacturer's suggested dilutions (1:1,000) prior to surface marker staining for 30 min at 4˚C.
For surface staining, filtered single cells were incubated for 30 min on ice with Fc Receptor Binding Inhibitor (eBioscience; Thermo Fisher Scientific, Inc.) diluted 1:10 in PBS. Cells were then incubated for 15 min in PBS containing 1.0 mM EDTA and 5% FBS (Gibco; Thermo Fisher Scientific, Inc.) together with the manufacturer's suggested dilutions of the following antibodies at room temperature: Alexa Fluor 700 anti-human CD3 (1:500; cat. no. 300324; Biolegend, Inc.), fluorescein isothiocyanate anti-human CD4 (1:500; cat. no. 317408; Biolegend, Inc.), PerCP/Cy5.5 anti-human CD8 (1:500; cat. no. 300924; Biolegend, Inc.), phycoerythrin anti-human CD25 (1:500; cat. no. 302606; Biolegend, Inc.), PE/Cy5 anti-human CD45 (1:500; cat. no. 304010; Biolegend, Inc.) and Brilliant Violet 650 anti-human CD127 (IL-7Rα; 1:500; cat. no. 351326; Biolegend, Inc.).
For cytokine staining, filtered single cells were incubated for 5 h with phorbol-12-myristate-13-acetate (50 ng/ml), ionomycin (1 µg/ml) and Brefeldin A (1:1,000) diluted in RPMI Medium (HyClone; GE Healthcare Life Sciences) containing 10% FBS and penicillin-streptomycin (1:100). Surface markers were stained as described above. Cells were fixed with fixation/permeabilization buffer (eBioscience; Thermo Fisher Scientific, Inc.) for 20 min at 4˚C according to the manufacturer's protocol. Then the intracellular staining plate containing Pacific Blue-conjugated anti-human IFN-γ (1:500; cat. no. 502517; Biolegend, Inc.), PECy7-conjugated anti-human IL-4 (1:500; cat. no. 500817; Biolegend, Inc.) and Brilliant Violet 510-conjugated anti-human IL-17 (1:500; cat. no. 512307; Biolegend, Inc.) was placed at 4˚C for 30 min, washed twice with fixation/permeabilization buffer (eBioscience; Thermo Fisher Scientific, Inc.) diluted in PBS (1:1,000) and stored at 4˚C until required for analysis with the CytoFLEX flow cytometer (Beckman Coulter, Inc., Brea, CA, USA). Results were analyzed using FlowJo software v9.3.2 (Tree Star, Inc., Ashland, OR, USA).
Statistical analysis. All statistical analysis was conducted using IBM SPSS Statistics software (version 22.0; IBM Corp, Armonk, NY, USA). Continuous data are presented as the mean ± standard deviation. Non-continuous data were compared by the Chi-square test or Fisher's exact (two-sided) test and continuous data were analyzed by the Mann-Whitney U test (two groups) or Kruskal-Wallis test followed by Tukey's post hoc test (>two groups). Kaplan-Meier curves and the log-rank test were used for survival analysis. Pearson's correlation analysis was used to evaluate the correlation between two variables. Univariate and multivariate Cox regression analyses were used to evaluate the significance of various parameters for survival. P<0.05 was considered to indicate a statistically significant difference. All experiments were repeated three times.
Results
TILs are closely associated with the clinicopathological characteristics of BC patients. A total of 72 patients were divided into two groups (low and high) according to their TIL density. There were 22 patients with high TILs using the quantitative method and this number was 20 when using the semiquantitative H&E staining. The result was comparable in evaluating the TILs by flow cytometry (Fig. 1A) and hematoxylin-eosin staining evaluation (Fig. 1B and C) . The association between TIL infiltration (low vs. high) and various clinicopathological parameters of BC patients are presented in Table I . A high infiltration of TILs was significantly associated with histological grade (P= 0.03), ER negativity (P= 0.006), HER2 positivity (P= 0.047) and BC molecular subtypes (P= 0.012). The infiltration of lymphocytes demonstrated no correlation with age, tumor size, lymph node status, or Ki-67 proliferation index (Table I) . compared with the healthy breast tissue ( Fig. 2A-C) . The association between CD4, CD8A and FOXP3 mRNA expression and clinical stage of BC patients was also evaluated as determined by the American Joint Committee on Cancer staging system. There was no significant difference in the mRNA ; R= 0.7; Fig. 4D ) mRNA expression. Furthermore, the association between the number of Tregs and cytokine secretion of T cells was studied (Fig. 5A) 
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CD8A and FOXP3 mRNA expression as prognostic markers in BC.
A total of 1,029 BC patients were evaluated for disease-free survival (DFS) and overall survival (OS). CD4 mRNA expression was not correlated with DFS (Log rank P= 0.275; Fig. 6A) ; however, it was significantly, positively correlated with OS (Log rank P= 0.028; Fig. 6B ). CD8A mRNA expression was both significantly, positively correlated with DFS (Log rank P= 0.017; Fig. 6C ) and OS (Log rank P= 0.002; Fig. 6D ). As for FOXP3 mRNA, its expression was significantly, positively correlated with DFS (Log rank P= 0.042; Fig. 6E ) and had no correlation with OS (Log rank P= 0.857; Fig. 6F ). In univariate analysis, correlations between DFS, OS and each clinicopathological parameter were examined for BC patients. CD8A, FOXP3 demonstrated a significant association with DFS (P= 0.018 and 0.044) and CD4. CD8A demonstrated a significant association with OS (P=0.029 and 0.003; Table II) . In multivariate analysis, CD8A, FOXP3 remained statistically significant (P= 0.013 and 0.028) in the analysis for DFS and CD8A remained statistically significant (P= 0.028) in the analysis for OS (Table II) . These data indicate that CD8A and FOXP mRNA expression could serve as independent prognosis markers in BC patients.
Discussion
Immune cells that infiltrate in BC maintain tissue homeostasis by continuous immunosurveillance and the initiation of inflammatory reactions (10, 23) . The assessment of TILs and their subsets in BC patients by histological methods (hematoxylin-eosin or immunohistochemistry staining) has been widely used in previous studies (7) (8) (9) 11, 16) , and suggestions have been made to improve their evaluation (22) . Although flow cytometry was seldom used to determine the distribution of TILs and their subsets, it has the advantage of being a quantitative technique that emphasizes the relative percentages of immune cell subsets. This value may be as important as the absolute number of immune cell subsets given that immune cells interact with each other in the tissue.
A number of studies have focused on the distribution of TILs and demonstrated that they are particularly prevalent in ductal carcinoma and in ER negative, high Ki67 BC patients with a high histological grade (24, 25) . Similar results were observed in the present study. TIL recruitment is influenced by a number of factors including C-X-C motif chemokine 9 expression (26, 27) , HLA class I histocompatibility antigen (28) , the presence of high endothelial venules in the tissue (29) , indoleamine 2,3-dioxygenase levels (30) and epithelial-mesenchymal transition (11) .
TIL subsets also have a particular distribution in BC. Seo et al (11) analyzed the correlation between absolute CD4 + T cells, CD8 + T cells and FOXP3 + TIL numbers, and the clinicopathological characteristics of tumors. In the present study, it was demonstrated that the percentage of tumor-infiltrating T cell subsets was associated with the BC molecular subtype. However, further study is required to determine the specific mechanism influencing the distribution of T cell subsets. CD4, CD8A and FOXP3 mRNA expression was also demonstrated to be increased in BC compared with healthy breast tissue, indicating the important role of tumor-infiltrating T cells in BC.
The prognostic value of tumor-infiltrating T cells, especially Tregs, in tumors is controversial. Tregs are usually considered an unfavorable factor because of their inhibitory function on other effector T cells. However, a high infiltration of Tregs was associated with a pathological complete response in BC (31, 32) . Seo et al (11) postulated that the suppression of Treg inhibitory function by chemotherapy facilitated the CD8 + cytotoxic T cell attack on the tumor, aiding the achievement of pathologic complete response. In the present study, the prognostic value of FOXP3 mRNA expression was evaluated There are certain limitations in the present study. This was only a preliminary study and more patients are required to validate the conclusion. In addition, more studies are needed to Figure 6 . Prognostic ability of CD4, CD8A and FOXP3 mRNA expression in BC patients. Kaplan-Meier survival curves of (A) disease-free survival and (B) overall survival with CD4 expression level. (C) Disease free survival and (D) overall survival with CD8A and (E) disease free survival and (F) overall survival with FOXP3 in BC patients. P-values were calculated using the log-rank method. All experiments were repeated three times. CD, cluster of differentiation; FOXP3, forkhead box protein P3; BC, breast cancer. investigate how the tumor-infiltrating T cells serve a positive role in BC.
Univariate analysis Multivariate analysis ------------------------------------------------------------------------------------------------------------------------------------------
In conclusion, the present study elucidated the distribution and interaction of TILs and their subsets in BC patients. The results of the present study also suggest that CD8 + T cells and Tregs may be used as reliable predictors of prognosis in BC, although further study is needed to determine the underlying mechanism. The present study identified potential targets for BC treatments that may provide more clinical choice in the future.
